Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
Diazoxide oral suspension, 2 mg per kg per dose
DRUG
2 trials
Sponsors
Columbia University
Conditions
Hyperinsulinemia
Insulin Resistance
Non-Alcoholic Fatty Liver Disease
Obesity
Prediabetic State
Phase 1
Glycemic Effect of Diazoxide in NAFLD
Completed
NCT05729282
Columbia University
Hyperinsulinemia, Insulin Resistance, Non-Alcoholic Fatty Liver Disease +1
Start: 2023-08-01
End: 2025-09-10
Updated: 2026-01-07
Effect of Insulin Lowering on Lipogenesis
Recruiting
NCT07403604
Columbia University
Hyperinsulinemia, Insulin Resistance, Non-Alcoholic Fatty Liver Disease +2
Start: 2026-07-01
End: 2029-09-30
Target: 25
Updated: 2026-07-06
Related Papers
2470-P: Optimizing Diazoxide to Study Hyperinsulinemia and De Novo Lipogenesis in MASLD
Diabetes
2026-06-05